Sign Out
Safety of use of ursodiol beyond 24 months is not established.
Non-visualizing gallbladder developing during ursodiol treatment predicts failure of complete stone dissolution and therapy should be discontinued.
Bile acids might be involved in the pathogenesis of human colon cancer in patients who have undergone a cholecystectomy.
Continue with Google